Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, End Users, Regions), Impact of COVID-19, 100 Company Profiles

Global Point Of Care Testing (POCT) Market (By Diagnostics Segment, Mode, End Users, Regions), Impact Of COVID-19, 100 Company Profiles - Forecast To 2026

The global point of care testing (POCT) market is predicted to exceed US$ 45 Billion by 2026. Rising incidence of infectious diseases and chronic conditions such as cardiovascular diseases and diabetes in developing countries such as India and China have stimulated demand for point of care testing services.

The global point of care testing (POCT) market is predicted to exceed US$ 45 Billion by 2026. POC testing appears to be headed for a bigger role in diagnosis and monitoring patient care. POCT or near-patient testing is a medical diagnostic test that allows physicians and medical staff to correctly attain real-time, lab-quality diagnostic results within minutes rather than hours. Over the years, the increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and most recently, convenience clinics. Furthermore, growing awareness about early disease diagnosis and prevention has stimulated the demand of point of care testing for detection of cancer and infectious disease at early stages. Rising incidence of infectious diseases and chronic conditions such as cardiovascular diseases and diabetes in developing countries such as India and China have stimulated demand for point of care testing services. As per the International Diabetes Federation (IDF), around 463 million people aged between 20-79 years had diabetes in 2019 globally. This number is estimated to reach 700 million by 2045. Hence, growing infectious diseases and chronic conditions will enhance the point of care testing market in the near future.

Impact of COVID-19 on Global Point of Care Testing Market

The COVID–19 outbreak has become a global stress test. The disease has infected over 92 Million people worldwide. Globally the death toll has reached 1,974,201 according to the latest statistics from the Worldometers (as of January 13, 2021). The number is still growing, and the duration of the pandemic is still difficult to predict. The COVID-19 outbreak has created a sense of urgency and panic among people globally. While people are being advised to stay indoors, healthcare professionals and researchers have registered a state of urgency. In this scenario, the point-of-care diagnostics forms the crux of increased testing. Manufacturers in the point-of-care testing market are focusing on developing novel technologies for maximum testing within a minimum period. The novel coronavirus has accelerated the research and development activities in the point-of-care diagnostics market. Development and production in maximum numbers is the need of the hour. Therefore, quick FDA approvals are proving to be the cherry on the cake for the growth of the point-of-care testing market.

By Diagnostics Segment - Global Point of Care Testing Market & Forecast

Based on diagnostics segment, the point of care testing market is dominated by blood glucose testing segment. Increasing prevalence of diabetes in developing as well as developed economies and the rising inclination of patients towards home testing is the major driver that will drive segmental growth over the forecast timeframe. Cardiac marker segment is expected to grow at the highest rate during the forecast period. The growing prevalence of cardiovascular ailments, increasing purchasing power, rise in the geriatric population, associated with high susceptibility to chronic diseases related to cardiac disorders, and economical diagnosis of chronic diseases in rural areas is expected to drive the market for cardiac markers. The goal of POC infectious disease testing is to detect pathogens in humans and determine a course of antimicrobial treatment that is most appropriate for the patient. Blood Coagulation and Clinical Chemistry segment is competing closely with each other to grab maximum share of the pie.

By Mode - Global Point of Care Testing Market & Forecast

On the basis of mode, the point of care testing market is dominated by OTC-based testing segment. OTC tests do not require dedicated space as clinical laboratory, and even their turn around time is quick. The Prescription based testing segment is expected to grow at the highest rate during the forecast period.

By End Users - Global Point of Care Testing Market & Forecast

Based on end users, the point of care testing market is segmented into Hospitals, Clinics, Laboratories, Home Care and Assisted Living Healthcare Facilities. Hospitals held majority of the point of care testing market, followed by Clinics. Increase in prevalence of chronic conditions such as cancer and cardiovascular diseases that require proper monitoring and prefer minimally invasive procedures are carried out in hospitals and clinics. The home care segment is expected to grow at the highest rate during the forecast period driven by increasing preference for home and remote monitoring and rising demand for rapid tests among home care users.

By Region - Global Point of Care Testing Market & Forecast

The point of care testing market, by region, is dominated by North America and is expected to maintain its position throughout the forecast period. This can be attributed to rising prevalence of chronic disorders and infectious diseases, which need portable and rapid diagnosis, increasing number of product approvals, and rising government initiatives to support the adoption of POCT in this region. Europe held second highest share of the point of care testing market. Asia-Pacific point of care testing market is expected to grow at the fastest rate during the forecast period driven by growing geriatric population base, rising prevalence of target diseases, increasing demand for home healthcare and the introduction of new products enabled with advanced technologies.

iGATE RESEARCH report titled “Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, End Users, Regions), Impact of COVID-19, 100 Company Profiles - Forecast to 2026” provides a comprehensive analysis of the Global Point of Care Testing Market.

This 223 Page report with 66 Figures and 10 Tables has been analyzed from 9 View Points:

1) Global - Point of Care Testing Market & Forecast (2010 - 2026)
2) Impact of COVID-19 on Global Point of Care Testing Market
3) Global - Point of Care Testing Market Share and Forecast (2010 - 2026)
4) By Diagnostics Segment - Global Point of Care Testing Market & Forecast (2010 - 2026)
5) By Mode - Global Point of Care Testing Market & Forecast (2010 - 2026)
6) By End Users - Global Point of Care Testing Market & Forecast (2010 - 2026)
7) By Region - Global Point of Care Testing Market & Forecast (2010 - 2026)
8) Global Point of Care Testing Market - 100 Company Profiles
9) Global Point of Care Testing Market - Growth Drivers & Challenges

By Diagnostics Segment - Global Point of Care Testing Market & Forecast

1. Blood Glucose Testing
2. Cardiac Marker Testing
3. Lipid Panel/Cholesterol Testing
4. Coagulation Testing
5. Infectious Disease Testing
6. Urinalysis Testing
7. Drug of Abuse Testing
8. Fecal Occult Blood Testing
9. Pregnancy & Fertility Testing
10. Tumor Marker Testing
11. Critical Care Testing
12. HbA1c Testing
13. Clinical Chemistry Testing
14. Bilirubin Testing
15. Hematology Testing

By Mode - Global Point of Care Testing Market & Forecast

• Prescription-based Testing
• OTC-based Testing

By End Users - Global Point of Care Testing Market & Forecast

1. Hospitals
2. Clinics
3. Laboratories
4. Assisted Living Healthcare Facilities
5. Home Care

By Region - Global Point of Care Testing Market & Forecast

1. North America
2. Europe
3. Asia Pacific
4. Latin America
5. Middle East & Africa

Global Point of Care Testing Market - 100 Company Profiles

1. Abbott Laboratories 2. Siemens Healthineers 3. Roche Diagnostics 4. Quest Diagnostics 5. Becton, Dickinson and Company 6. ACON Laboratories 7. Abaxis, Inc 8. Abingdon Health, Ltd 9. Access Bio, Inc. 10. AccuBioTech Co, Ltd. 11. Akers Biosciences, Inc. 12. Alfa Scientific Designs, Inc 13. American Bio Medica Corporation 14. AmniSure International 15. Aquila Diagnostic Systems, Inc 16. ARKRAY Inc 17. Artron Laboratories Inc. 18. Ascensia Diabetes Care Holdings AG 19. Ativa Medical Corporation 20. Atlas Link Biotech Co., Ltd 21. Audit Diagnostics 22. Augurix Diagnostics 23. Autobio Diagnostics Co., Ltd 24. Axxin 25. Beckman Coulter, Inc 26. Bhat Bio-Tech India Private Ltd. 27. bioLytical Laboratories 28. BioMedomics, Inc 29. Biomerica, Inc. 30. bioMerieux SA 31. Biophor Diagnostics, Inc 32. Bio-Rad Laboratories Inc. 33. Bioscan Screening Systems, Inc. 34. Biosensia Ltd. 35. BTNX Inc. 36. Boditech Med Inc 37. Xiamen Boson Biotech Co. Ltd 38. Calypte Biomedical Corporation 39. Cepheid, Inc 40. Chembio Diagnostic Systems, Inc 41. Clarity Diagnostics, LLC 42. Confirm Biosciences 43. CTK Biotech, Inc. 44. Daktari Diagnostics 45. Danaher Corporation 46. Dexcom, Inc 47. DIALAB GmbH 48. DiaSys Diagnostic Systems GmbH 49. Diazyme Laboratories, Inc. 50. DNA Electronics Ltd. (DNAe) 51. EKF Diagnostics Holdings plc 52. ELITechGroup, Inc. 53. Eurolyser Diagnostica GmbH 54. Exact Sciences Corporation 55. Exalenz Bioscience Ltd 56. Genedrive plc 57. GeTein BioMedical, Inc. 58. Helena Laboratories 59. Hemosure, Inc. 60. Immunostics, Inc. 61. Instrumentation Laboratory 62. JAL Innovation PTE LTD 63. Jant Pharmacal Corporation 64. LamdaGen Corporation 65. LifeScan, Inc 66. LifeSign, LLC 67. MBio Diagnostics, Inc (Now LightDeck Diagnostics) 68. Medix Biochemica 69. Medtronic, Inc 70. A. Menarini Diagnostics S.R.L. 71. Meridian Bioscience, Inc 72. Nano-Ditech Corporation 73. Noble Medical, Inc 74. Nova Biomedical, Corp. 75. Oasis Diagnostics Corporation 76. OPKO Health, Inc 77. OPTI Medical Systems, Inc 78. OraSure Technologies, Inc 79. Polymed Therapeutics Inc. 80. Preventis GmbH 81. Princeton Biomeditech Corporation 82. QuantuMDx Group Limited 83. Radiometer Medical A/S 84. Response Biomedical Corp 85. Reszon Diagnostics International Sdn. Bhd. 86. Samsung Healthcare 87. Savyon Diagnostics 88. Sekisui Diagnostics LLC 89. Siloam Biosciences, Inc 90. Sysmex Corporation 91. TECHLAB, Inc. 92. Teco Diagnostics 93. Trinity Biotech PLC 94. Trividia Health 95. Tulip Diagnostics Ltd 96. Veredus Laboratories PTE Ltd 97. Vircell 98. WAMA Diagnostica 99. Wave 80 Biosciences 100. Werfen

Data Source

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

1. Executive Summary

2. Impact of COVID-19 on Global Point of Care Testing Market

3. Global - Point of Care Testing Market & Forecast (2010 - 2026)

4. Global - Point of Care Testing Market Share & Forecast (2010 - 2026)

4.1 By Diagnostics Segment - Global Point of Care Testing Market Share & Forecast
4.2 By Mode - Global Point of Care Testing Market Share & Forecast
4.3 By End Users - Global Point of Care Testing Market Share & Forecast
4.4 By Region - Point of Care Testing Market Share & Forecast

5. By Diagnostics Segment - Global Point of Care Testing Market & Forecast (2010 - 2026)

5.1 Blood Glucose Testing Market & Forecast
5.2 Cardiac Marker Testing Market & Forecast
5.3 Lipid Panel/Cholesterol Testing Market & Forecast
5.4 Coagulation Testing Market & Forecast
5.5 Infectious Disease Testing Market & Forecast
5.6 Urinalysis Testing Market & Forecast
5.7 Drug of Abuse Testing Market & Forecast
5.8 Fecal Occult Blood Testing Market & Forecast
5.9 Pregnancy & Fertility Testing Market & Forecast
5.10 Tumor Marker Testing Market & Forecast
5.11 Critical Care Testing Market & Forecast
5.12 HbA1c Testing Market & Forecast
5.13 Clinical Chemistry Testing Market & Forecast
5.14 Bilirubin Testing Market & Forecast
5.15 Hematology Testing Market & Forecast

6. By Mode - Global Point of Care Testing Market & Forecast (2010 - 2026)

6.1 Prescription-based Testing Market & Forecast
6.2 OTC-based Testing Market & Forecast

7. By End Users - Global Point of Care Testing Market & Forecast (2010 - 2026)

7.1 Hospitals - Point of Care Testing Market & Forecast
7.2 Clinics - Point of Care Testing Market & Forecast
7.3 Laboratories - Point of Care Testing Market & Forecast
7.4 Assisted Living Healthcare Facilities - Point of Care Testing Market & Forecast
7.5 Home Care - Point of Care Testing Market & Forecast

8. By Region - Global Point of Care Testing Market & Forecast (2010 - 2026)

8.1 North America - Point of Care Testing Market & Forecast
8.2 Europe - Point of Care Testing Market & Forecast
8.3 Asia Pacific - Point of Care Testing Market & Forecast
8.4 Latin America - Point of Care Testing Market & Forecast
8.5 Middle East and Africa - Point of Care Testing Market & Forecast

9. Point of Care Testing Market - Company Profiles

9.1 Abbott Laboratories

9.1.1 Company Overview
9.1.2 Product Portfolio
9.1.3 Financial Insight
9.1.4 Business Strategy

9.2 Siemens Healthineers

9.2.1 Company Overview
9.2.2 Product Portfolio
9.2.3 Financial Insight
9.2.4 Business Strategy

9.3 Roche Diagnostics

9.3.1 Company Overview
9.3.2 Product Portfolio
9.3.3 Financial Insight
9.3.4 Business Strategy

9.4 Quest Diagnostics

9.4.1 Company Overview
9.4.2 Product Portfolio
9.4.3 Financial Insight
9.4.4 Business Strategy

9.5 Becton, Dickinson and Company

9.5.1 Company Overview
9.5.2 Product Portfolio
9.5.3 Financial Insight
9.5.4 Business Strategy

9.6 ACON Laboratories

9.6.1 Company Overview
9.6.2 Product Portfolio

9.7 Abaxis, Inc.

9.7.1 Company Overview
9.7.2 Product Portfolio

9.8 Abingdon Health, Ltd.

9.8.1 Company Overview
9.8.2 Product Portfolio

9.9 Access Bio, Inc.

9.9.1 Company Overview
9.10 AccuBioTech Co, Ltd.

9.11 Akers Biosciences, Inc.
9.12 Alfa Scientific Designs, Inc
9.13 American Bio Medica Corporation
9.14 AmniSure International
9.15 Aquila Diagnostic Systems, Inc
9.16 ARKRAY Inc
9.17 Artron Laboratories Inc.
9.18 Ascensia Diabetes Care Holdings AG
9.19 Ativa Medical Corporation
9.20 Atlas Link Biotech Co., Ltd
9.21 Audit Diagnostics
9.22 Augurix Diagnostics
9.23 Autobio Diagnostics Co., Ltd
9.24 Axxin
9.25 Beckman Coulter, Inc
9.26 Bhat Bio-Tech India Private Ltd. (BBI)
9.27 bioLytical Laboratories
9.28 BioMedomics, Inc
9.29 Biomerica, Inc.
9.30 bioMerieux SA
9.31 Biophor Diagnostics, Inc
9.32 Bio-Rad Laboratories Inc162
9.33 Bioscan Screening Systems, Inc162
9.34 Biosensia Ltd.
9.35 BTNX Inc.
9.36 Boditech Med Inc
9.37 Xiamen Boson Biotech Co. Ltd
9.38 Calypte Biomedical Corporation
9.39 Cepheid, Inc
9.40 Chembio Diagnostic Systems, Inc
9.41 Clarity Diagnostics, LLC
9.42 Confirm Biosciences
9.43 CTK Biotech, Inc.
9.44 Daktari Diagnostics
9.45 Danaher Corporation
9.46 Dexcom, Inc
9.47 DIALAB GmbH
9.48 DiaSys Diagnostic Systems GmbH
9.49 Diazyme Laboratories, Inc.
9.50 DNA Electronics Ltd. (DNAe)
9.51 EKF Diagnostics Holdings plc
9.52 ELITechGroup, Inc.
9.53 Eurolyser Diagnostica GmbH
9.54 Exact Sciences Corporation
9.55 Exalenz Bioscience Ltd.
9.56 Genedrive plc
9.57 GeTein BioMedical, Inc.
9.58 Helena Laboratories
9.59 Hemosure, Inc.
9.60 Immunostics, Inc.
9.61 Instrumentation Laboratory
9.62 JAL Innovation PTE LTD
9.63 Jant Pharmacal Corporation
9.64 LamdaGen Corporation
9.65 LifeScan, Inc
9.66 LifeSign, LLC
9.67 MBio Diagnostics, Inc (Now LightDeck Diagnostics)
9.68 Medix Biochemica
9.69 Medtronic, Inc.
9.70 A. Menarini Diagnostics S.R.L.
9.71 Meridian Bioscience, Inc
9.72 Nano-Ditech Corporation
9.73 Noble Medical, Inc
9.74 Nova Biomedical, Corp.
9.75 Oasis Diagnostics Corporation
9.76 OPKO Health, Inc
9.77 OPTI Medical Systems, Inc
9.78 OraSure Technologies, Inc
9.79 Polymed Therapeutics Inc.
9.80 Preventis GmbH
9.81 Princeton Biomeditech Corporation
9.82 QuantuMDx Group Limited
9.83 Radiometer Medical A/S
9.84 Response Biomedical Corp
9.85 Reszon Diagnostics International Sdn. Bhd.
9.86 Samsung Healthcare
9.87 Savyon Diagnostics
9.88 Sekisui Diagnostics LLC
9.89 Siloam Biosciences, Inc
9.90 Sysmex Corporation
9.91 TECHLAB, Inc.
9.92 Teco Diagnostics
9.93 Trinity Biotech PLC
9.94 Trividia Health
9.95 Tulip Diagnostics Ltd
9.96 Veredus Laboratories PTE Ltd
9.97 Vircell
9.98 WAMA Diagnostica
9.99 Wave 80 Biosciences
9.100 Werfen

10. Global Point of Care Testing Market - Growth Drivers

10.1 Point-of-care Testing: A Step to the Future
10.2 High Prevalence of Chronic and Infectious Diseases
10.3 Continued Expansion of Point of Care Including Self Testing
10.3.1 The Promise of Point-of-Care Testing
10.3.2 Future of Point of Care Testing - The ‘Worried Well’
10.3.3 Hub and Spoke
10.3.4 Education

11. Global Point of Care Testing Market - Challenges

11.1 Point of Care (POC) Testing Barriers in Low & Middle-Income Countries
11.1.1 Barriers to Adoption & Scale-up of POC Technologies
11.1.2 Technical, Administrative & Operational Barriers of Point of Care Tests
11.1.3 Health System Related Barriers of Point of Care Tests
11.1.4 Economic Barriers of Point of Care Tests
11.2 Policy/Regulatory Guidelines and Funding Challenges
11.3 Infrastructure Barriers and Challenges with POC Diagnostics Development

List of Figures:

Figure 3-1: Global - Point of Care Testing Market (Million US$), 2010 - 2020
Figure 3-2: Global - Forecast for Point of Care Testing Market (Million US$), 2021 - 2026

Figure 5-1: Global - Blood Glucose Testing Market (Million US$), 2010 - 2020
Figure 5-2: Global - Forecast for Blood Glucose Testing Market (Million US$), 2021 - 2026
Figure 5-3: Global - Cardiac Marker Testing Market (Million US$), 2010 - 2020
Figure 5-4: Global - Forecast for Cardiac Marker Testing Market (Million US$), 2021 - 2026
Figure 5-5: Global - Lipid Panel/Cholesterol Testing Market (Million US$), 2010 - 2020
Figure 5-6: Global - Forecast for Lipid Panel/Cholesterol Testing Market (Million US$), 2021 - 2026
Figure 5-7: Global - Coagulation Testing Market (Million US$), 2010 - 2020
Figure 5-8: Global - Forecast for Coagulation Testing Market (Million US$), 2021 - 2026
Figure 5-9: Global - Infectious Disease Testing Market (Million US$), 2010 - 2020
Figure 5-10: Global - Forecast for Infectious Disease Testing Market (Million US$), 2021 - 2026
Figure 5-11: Global - Urinalysis Testing Market (Million US$), 2010 - 2020
Figure 5-12: Global - Forecast for Urinalysis Testing Market (Million US$), 2021 - 2026
Figure 5-13: Global - Drug of Abuse Testing Market (Million US$), 2010 - 2020
Figure 5-14: Global - Forecast for Drug of Abuse Testing Market (Million US$), 2021 - 2026
Figure 5-15: Global - Fecal Occult Blood Testing Market (Million US$), 2010 - 2020
Figure 5-16: Global - Forecast for Fecal Occult Blood Testing Market (Million US$), 2021 - 2026
Figure 5-17: Global - Pregnancy & Fertility Testing Market (Million US$), 2010 - 2020
Figure 5-18: Global - Forecast for Pregnancy & Fertility Testing Market (Million US$), 2021 - 2026
Figure 5-19: Global - Tumor Marker Testing Market (Million US$), 2010 - 2020
Figure 5-20: Global - Forecast for Tumor Marker Testing Market (Million US$), 2021 - 2026
Figure 5-21: Global - Critical Care Testing Market (Million US$), 2010 - 2020
Figure 5-22: Global - Forecast for Critical Care Testing Market (Million US$), 2021 - 2026
Figure 5-23: Global - HbA1c Testing Market (Million US$), 2010 - 2020
Figure 5-24: Global - Forecast for HbA1c Testing Market (Million US$), 2021 - 2026
Figure 5-25: Global - Clinical Chemistry Testing Market (Million US$), 2010 - 2020
Figure 5-26: Global - Forecast for Clinical Chemistry Testing Market (Million US$), 2021 - 2026
Figure 5-27: Global - Bilirubin Testing Market (Million US$), 2010 - 2020
Figure 5-28: Global - Forecast for Bilirubin Testing Market (Million US$), 2021 - 2026
Figure 5-29: Global - Hematology Testing Market (Million US$), 2010 - 2020
Figure 5-30: Global - Forecast for Hematology Testing Market (Million US$), 2021 - 2026

Figure 6-1: Global - Prescription-based Testing Market (Million US$), 2010 - 2020
Figure 6-2: Global - Forecast for Prescription-based Testing Market (Million US$), 2021 - 2026
Figure 6-3: Global - OTC-based Testing Market (Million US$), 2010 - 2020
Figure 6-4: Global - Forecast for OTC-based Testing Market (Million US$), 2021 - 2026

Figure 7-1: Hospitals - Point of Care Testing Market (Million US$), 2010 - 2020
Figure 7-2: Hospitals - Forecast for Point of Care Testing Market (Million US$), 2021 - 2026
Figure 7-3: Clinics - Point of Care Testing Market (Million US$), 2010 - 2020
Figure 7-4: Clinics - Forecast for Point of Care Testing Market (Million US$), 2021 - 2026
Figure 7-5: Laboratories - Point of Care Testing Market (Million US$), 2010 - 2020
Figure 7-6: Laboratories - Forecast for Point of Care Testing Market (Million US$), 2021 - 2026
Figure 7-7: Assisted Living Healthcare Facilities - Point of Care Testing Market (Million US$), 2010 - 2020
Figure 7-8: Assisted Living Healthcare Facilities - Forecast for Point of Care Testing Market (Million US$), 2021 - 2026
Figure 7-9: Home Care - Point of Care Testing Market (Million US$), 2010 - 2020
Figure 7-10: Home Care - Forecast for Point of Care Testing Market (Million US$), 2021 - 2026

Figure 8-1: North America - Point of Care Testing Market (Million US$), 2010 - 2020
Figure 8-2: North America - Forecast for Point of Care Testing Market (Million US$), 2021 - 2026
Figure 8-3: Europe - Point of Care Testing Market (Million US$), 2010 - 2020
Figure 8-4: Europe - Forecast for Point of Care Testing Market (Million US$), 2021 - 2026
Figure 8-5: Asia Pacific - Point of Care Testing Market (Million US$), 2010 - 2020
Figure 8-6: Asia Pacific - Forecast for Point of Care Testing Market (Million US$), 2021 - 2026
Figure 8-7: Latin America - Point of Care Testing Market (Million US$), 2010 - 2020
Figure 8-8: Latin America - Forecast for Point of Care Testing Market (Million US$), 2021 - 2026
Figure 8-9: Middle East and Africa - Point of Care Testing Market (Million US$), 2010 - 2020
Figure 8-10: Middle East and Africa - Forecast for Point of Care Testing Market (Million US$), 2021 - 2026

Figure 9-1: Abbott Laboratories - Global Diagnostics Sales (Million US$), 2013 - 2019
Figure 9-2: Abbott Laboratories - Forecast for Global Diagnostics Sales (Million US$), 2020 - 2026
Figure 9-3: Siemens Healthineers - Global Diagnostics Sales (Million US$), 2013 - 2019
Figure 9-4: Siemens Healthineers - Forecast for Global Diagnostics Sales (Million US$), 2020 - 2026
Figure 9-5: Roche Diagnostics - Global Sales (Million US$), 2013 - 2019
Figure 9-6: Roche Diagnostics - Forecast for Global Sales (Million US$), 2020 - 2026
Figure 9-7: Quest Diagnostics - Net Sales (Million US$), 2014 - 2019
Figure 9-8: Quest Diagnostics - Forecast for Net Sales (Million US$), 2020 - 2026
Figure 9-9: Becton, Dickinson and Company - Global Diagnostics Sales (Million US$), 2014 - 2020
Figure 9-10: Becton, Dickinson and Company - Forecast for Global Diagnostics Sales (Million US$), 2021 - 2026

List of Tables:

Table 4-1: By Diagnostics Segment - Point of Care Testing Market Share (Percent), 2010 - 2020
Table 4-2: By Diagnostics Segment - Forecast for Point of Care Testing Market Share (Percent), 2021 - 2026
Table 4-3: By Mode - Point of Care Testing Market Share (Percent), 2010 - 2020
Table 4-4: By Mode - Forecast for Point of Care Testing Market Share (Percent), 2021 - 2026
Table 4-5: By End Users - Point of Care Testing Market Share (Percent), 2010 - 2020
Table 4-6: By End Users - Forecast for Point of Care Testing Market Share (Percent), 2021 - 2026
Table 4-7: By Region - Point of Care Testing Market Share (Percent), 2010 - 2020
Table 4-8: By Region - Forecast for Point of Care Testing Market Share (Percent), 2021 - 2026

Table 9-1: Eurolyser Diagnostica GmbH - Point-of-Care Test Portfolio

Table 11-1: POCT - Barriers to Adoption and Scale-up of POC Technologies

Global Point Of Care Testing (POCT) Market (By Diagnostics Segment, Mode, End Users, Regions), Impact Of COVID-19, 100 Company Profiles - Forecast To 2026

PRICING

Categories